T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Recent evidence has highlighted the fact that axon injury is an important component of multiple sclerosis pathology. The issue of whether a CNS antigen-specific immune response is required to produce axon injury remains unresolved. We investigated the extent and time course of axon injury in a rodent model of a delayed-type hypersensitivity (DTH) reaction directed against the mycobacterium bacille Calmette-Guérin (BCG). Using MRI, we determined whether the ongoing axon injury is restricted to the period during which the blood-brain barrier is compromised. DTH lesions were initiated in adult rats by intracerebral injection of heat-killed BCG followed by a peripheral challenge with BCG. Our findings demonstrate that a DTH reaction to a non-CNS antigen within a CNS white matter tract leads to axon injury. Ongoing axon injury persisted throughout the 3-month period studied and was not restricted to the period of blood-brain barrier breakdown, as detected by MRI enhancing lesions. We have previously demonstrated that matrix metalloproteinases (MMPs) are upregulated in multiple sclerosis plaques and DTH lesions. In this study we demonstrated that microinjection of activated MMPs into the cortical white matter results in axon injury. Our results show that axon injury, possibly mediated by MMPs, is immunologically non-specific and may continue behind an intact blood-brain barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 1×
“Recent evidence suggests a correlation between axon injury and the number of CD8 T cells present in a lesion (Bitsch et al., 2000).”
BackgroundPrecursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733
Stys, P., Waxman, S., & Ransom, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00430.1992 · Cited by 662
Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin
Chen, Z.-L., & Strickland, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80483-3 · Cited by 632 · cited 1×
“The precise mechanism by which an MMP leads to axon injury is not clear, but the role of extracellular matrix remodelling in neuronal cell death has been demonstrated recently (Chen and Strickland, 1997).”
BackgroundKappos, L., Moeri, D., Radue, E. W., Schoetzau, A., Schweikert, K., Barkhof, F., Miller, D., Guttmann, C. R., Weiner, H. L., Gasperini, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03053-0 · Cited by 499 · cited 1×
“A protocol used widely to assess lesion activity is to assay the number of contrast agent enhancing lesions (Kappos et al., 1999) where the BBB is compromised, presumably as a result of the activity of invading leucocytes.”
MethodBhakoo, K. K., & Pearce, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740254.x · Cited by 236
Cited by
Castelli, F. (2002) · Brain · doi:10.1093/brain/awf189 · Cited by 1,377
Donnelly, D. J., & Popovich, P. G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.009 · Cited by 995
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Myelination and the trophic support of long axons
Nave, K.-A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2797 · Cited by 648
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582
Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
Axonal damage: a key predictor of outcome in human CNS diseases
Medana, I. M., & Esiri, M. M. (2003) · Brain · doi:10.1093/brain/awg061 · Cited by 464
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
Self-citationProspective study on the relationship between infections and multiple sclerosis exacerbations
Buljevac, D., Flach, H. Z., Hop, W. C. J., Hijdra, D., Laman, J. D., Savelkoul, H. F. J., van der Meché, F. G. A., van Doorn, P. A., & Hintzen, R. Q. (2002) · Brain · doi:10.1093/brain/awf098 · Cited by 427
Targeting leukocyte MMPs and transmigration
Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 426
Bar-Or, A. (2003) · Brain · doi:10.1093/brain/awg285 · Cited by 360
Zipp, F., & Aktas, O. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.006 · Cited by 348
The Neuropathological and Behavioral Consequences of Intraspinal Microglial/Macrophage Activation
Popovich, P. G., Guan, Z., McGaughy, V., Fisher, L., Hickey, W. F., & Basso, D. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.623 · Cited by 295
Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G., & Yong, V. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11127.2003 · Cited by 260
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis
Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., & Reynolds, R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00177.x · Cited by 192
Papadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Vereyken, E. J., Heijnen, P. D., Baron, W., de Vries, E. H., Dijkstra, C. D., & Teunissen, C. E. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-58 · Cited by 108
The neuroprotective effect of doxycycline on neurodegenerative diseases
Santa-Cecília, F. V., Leite, C. A., Del-Bel, E., & Raisman-Vozari, R. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00015-z · Cited by 73
Broom, K. A., Anthony, D. C., Blamire, A. M., Waters, S., Styles, P., Perry, V. H., & Sibson, N. R. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600020 · Cited by 47
“…edema, demyelination and axonal loss have all been reported to yield similar increases in signal intensity on T2-weighted images (Bruck et al, 1997), and in MS patients it has been suggested that acute-lesionassociated T2 hyperintensities most closely reflect demyelination (Nijeholt et al, 2001).”
BackgroundWang, P., Gorter, R. P., de Jonge, J. C., Nazmuddin, M., Zhao, C., Amor, S., Hoekstra, D., & Baron, W. (2018) · Glia · doi:10.1002/glia.23328 · Cited by 40
Chauhan, P., Kakkar, A. K., Singh, H., & Gautam, C. S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1838276 · Cited by 12
Metadata
- Authors
- Newman, T. A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-11-01
- Volume
- 124
- Issue
- 11
- Pages
- 2203-2214
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2084574028
- Cited by
- 143
- References
- 8
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.